Construction of a Prognostic Model for Predicting Colorectal Cancer Prognosis and Response to Immunotherapy Based on Cuproptosis-Associated lncRNAs

Figure 8

Correlation between immunotherapy responsiveness and CRLs risk score model. (a) Association of MSI status and risk score. (b) IPS scores between high and low CRLs score groups when CTLA‐4 negative and PD1 positive. (c) IPS scores between high and low CRLs score groups when CTLA‐4 positive and PD1 negative. (d‐f) The differences in immune exclusion, immune dysfunction, and TIDE scores between high-risk and low-risk groups.

(a)

(b)

(c)

(d)

(e)

(f)